Patents by Inventor Peter Crisalli

Peter Crisalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240150824
    Abstract: The present disclosure relates to tagged nucleoside-5?-oligophosphates having a positively charged polymer tag structure and components thereof. Such nucleoside-5?-oligophosphates are useful, for example, in nanopore-based sequencing-by-synthesis applications. Also disclosed herein are nanopore constructs engineered to have additional negatively-charged moieties in the channel of the nanopore. Such nanopores can be useful, for example, for providing a repellant force against template and/or primer nucleic acids inserting into the pore during a nucleic sequence-by-synthesis process. The tagged nucleoside-5?-oligophosphates and nanopores disclosed herein can be used together to provide nanopore-based nucleic acid sequencing-by-synthesis systems and processes having reduced background tag levels and improved throughput.
    Type: Application
    Filed: August 9, 2021
    Publication date: May 9, 2024
    Inventors: Aruna Ayer, Frank Bergmann, Peter Crisalli, Lars Hillringhaus, Omid Khakshoor, Hannes Kuchelmeister, Rongxin Nie, Marshall W. Porter, Christoph Seidel, Seong-Ho Shin, Meng Taing, Adolfo Vargas
  • Publication number: 20240010668
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: August 11, 2023
    Publication date: January 11, 2024
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Patent number: 11802276
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: October 31, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Helen Franklin, Cynthia Cech, Timothy Kellogg Craig, Aruna Ayer, Kirti Dhiman, Natalie B. Chechelski Johnston, Joshua N. Mabry, Arkadiusz Bibillo, Peter Crisalli, Randall W. Davis
  • Patent number: 11773130
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: October 3, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Patent number: 11746337
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: September 5, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Helen Franklin, Cynthia Cech, Timothy Kellogg Craig, Aruna Ayer, Kirti Dhiman, Natalie B. Chechelski Johnston, Joshua N. Mabry, Arkadiusz Bibillo, Peter Crisalli, Randall W. Davis
  • Publication number: 20230159999
    Abstract: This application discloses compositions comprising primer compounds that reduce or block deleterious threading into a nanopore of nucleic acid strands displaced by a nanopore-linked polymerase, for example during the use of a nanopore device for nucleic acid sequencing. Also disclosed are methods for using the compositions to reduce deleterious threading events during nanopore-based nucleic acid detection techniques, such as nanopore sequencing.
    Type: Application
    Filed: August 4, 2022
    Publication date: May 25, 2023
    Inventors: Aruna Ayer, David Beyer, Peter Crisalli, Kirti Dhiman, Helen Franklin, Swathi Chakravarthy, Omid Khakshoor, Blake Langdon, Meng Taing, Adolfo Vargas
  • Patent number: 11525124
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Grant
    Filed: May 11, 2020
    Date of Patent: December 13, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Helen Franklin, Cynthia Cech, Timothy Kellogg Craig, Aruna Ayer, Kirti Dhiman, Natalie B. Chechelski Johnston, Joshua N. Mabry, Arkadiusz Bibillo, Peter Crisalli, Randall W. Davis
  • Publication number: 20220348604
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: July 6, 2022
    Publication date: November 3, 2022
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Patent number: 11440933
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: September 13, 2022
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Patent number: 11293060
    Abstract: The present invention relates to improving the processing rate of a sequencing reaction, for example in a nanopore sequencing reaction, by means of using improved nucleoside-tags. The tags are linked to the nucleoside phosphate via a Pictet Spengler reaction. Exemplary sequencing reactions that are improved by the present methods include nanopore-based nucleic acid sequencing-by-synthesis reactions.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: April 5, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Ian Quang Chau, Peter Crisalli, Hannah Marie Kallewaard-Lum, Hannes Kuchelmeister, Sebastian Johannes Pomplun, Hasham Saqib, Christian Wellner
  • Publication number: 20220041642
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 10, 2022
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Publication number: 20210317521
    Abstract: The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for nanopore-based nucleic acid detection and sequencing.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Peter Crisalli, Andrew Trans, Ashwini Bhat
  • Patent number: 11008613
    Abstract: The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for nanopore-based nucleic acid detection and sequencing.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: May 18, 2021
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Peter Crisalli, Andrew Trans, Ashwini Bhat
  • Publication number: 20210088511
    Abstract: Provided are nanopore-based methods, compositions, and systems for assessing analyte-ligand interactions and analyte concentration in a fluid solution. The compositions include an analyte detection complex that is associated with a nanopore to form a nanopore assembly, the analyte detection complex including an analyte ligand. As a first voltage is applied across the nanopore assembly, the analyte ligand is presented to an analyte in the solution. As a second voltage that is opposite in polarity to the first voltage is applied across the nanopore assembly, the analyte binds to the analyte. By comparing the total number of analyte-ligand binding pairs to a control binding count, the concentration of the analyte can be determined. In other examples, further increasing the second voltage can result in dissociation of the analyte-ligand pair, from which a dissociation voltage—and hence a dissociation constant—can be determined.
    Type: Application
    Filed: September 30, 2020
    Publication date: March 25, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Peter CRISALLI, Dmitriy GREMYACHINSKIY, Dieter HEINDL, Hannes KUCHELMEISTER, Michael SCHRAEML, Andrew TRANS
  • Publication number: 20200277581
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Application
    Filed: May 11, 2020
    Publication date: September 3, 2020
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Helen FRANKLIN, Cynthia CECH, Timothy Kellogg CRAIG, Aruna AYER, Kirti DHIMAN, Natalie B. CHECHELSKI JOHNSTON, Joshua N. MABRY, Arkadiusz BIBILLO, Peter CRISALLI, Randall W. DAVIS
  • Publication number: 20200270589
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Application
    Filed: May 11, 2020
    Publication date: August 27, 2020
    Applicant: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: Helen FRANKLIN, Cynthia CECH, Timothy Kellogg CRAIG, Aruna AYER, Kirti DHIMAN, Natalie B. CHECHELSKI JOHNSTON, Joshua N. MABRY, Arkadiusz BIBILLO, Peter CRISALLI, Randall W. DAVIS
  • Publication number: 20200216894
    Abstract: The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for nanopore-based nucleic acid detection and sequencing.
    Type: Application
    Filed: March 20, 2020
    Publication date: July 9, 2020
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Peter Crisalli, Andrew Trans, Ashwini Bhat
  • Patent number: 10669580
    Abstract: The present disclosure relates to compounds comprising a negatively-charged polymer moiety which is capable of entering a nanopore and upon entering a nanopore in the presence of positive ions results in an increased flow of the positive ions through the nanopore. The present disclosure provides methods of preparing the compounds and for their use as nanopore-detectable tags, in particular, for nanopore-based nucleic acid detection and sequencing.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: June 2, 2020
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Peter Crisalli, Andrew Trans, Ashwini Bhat
  • Publication number: 20200040392
    Abstract: The present invention relates to improving the processing rate of a sequencing reaction, for example in a nanopore sequencing reaction, by means of using improved nucleoside-tags. The tags are linked to the nucleoside phosphate via a Pictet Spengler reaction. Exemplary sequencing reactions that are improved by the present methods include nanopore-based nucleic acid sequencing-by-synthesis reactions.
    Type: Application
    Filed: October 8, 2019
    Publication date: February 6, 2020
    Inventors: Frank Bergmann, Ian Quang Chau, Peter Crisalli, Hannah Marie Kallewaard-Lum, Hannes Kuchelmeister, Sebastian Johannes Pomplun, Hasham Saqib, Christian Wellner
  • Publication number: 20180340157
    Abstract: Disclosed are methods for isolating polymerase complexes from a mixture of polymerase complex components. The polymerase complexes can comprise a nanopore to provide isolated nanopore sequencing complexes. The methods relate to the positive and negative isolation of the polymerase complexes and/or nanopore sequencing complexes. Also disclosed is a nucleic acid adaptor for isolating active polymerase complexes, polymerase complexes comprising the nucleic acid adaptor, and methods for isolating active polymerase complexes using the nucleic acid adaptor.
    Type: Application
    Filed: May 24, 2018
    Publication date: November 29, 2018
    Inventors: Helen FRANKLIN, Cynthia CECH, Timothy Kellogg CRAIG, Aruna AYER, Kirti DHIMAN, Natalie B. CHECHELSKI JOHNSTON, Joshua N. MABRY, Arkadiusz BIBILLO, Peter CRISALLI, Randall W. DAVIS